Sfoglia per AUTORE
FERRERI AJM
Collezione AOU Novara

  

Items : 10

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.
2024
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Bonomini L; Vitolo U; Cesaretti M; Esposito F; Pirosa MC; Pinotti G; Dore F; Pisani F; Zanni M; Ghiggi C; Liberati AM; Annibali O; Cabras MG; Celli M; Orsucci L; Tani M; Bruna R; Vanazzi A; Tucci A; Merli F; Balzarotti M; Gaidano G; Sassone M; Zucca E; Botto B; Stathis A; Ferreri AJM; Chiappella A; Conconi A; et alii...

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2024 Jan;35(1):118-129. doi: 10.1016/j.annonc.2023.10.095. Epub 2023 Nov 3.
2024
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Vitolo U; Bottelli C; Ciccone G; Boccomini C; Bossi E; Luminari S; Pennese E; Re F; Benedetti F; Ferreri AJM; Latte G; Patti C; Pastore D; Pinto A; Ghiggi C; Cavallo F; Milone G; Tani M; Corradini P; Gaidano G; Pavone V; Puccini B; Arcari A; Volpetti S; Tucci A; Zilioli VR; Bolis S; Botto B; Evangelista A; et alii...

2022
AOU Novara

Steffanoni S; Calimeri T; Laurenge A; Fox CP; Soussain C; Grommes C; Tisi MC; Boot J; Crosbie N; Visco C; Arcaini L; Chaganti S; Sassone MC; Alencar A; Armiento D; Romano I; Dietrich J; Itchaki G; Bruna R; Fracchiolla NS; Arletti L; Venditti A; Booth S; Musto P; Hoang Xuan K; Batchelor TT; Cwynarski K; Ferreri AJM;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.
2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Merli F; Passamonti F; Candoni A; Krampera M; Venditti A; Selleri C; Tosi P; Lanza F; Conconi A; La Barbera EO; Gambacorti-Passerini C; Visani G; Vallisa D; Rigacci L; Armiento D; Gherlinzoni F; Tafuri A; Galimberti S; Bocchia M; Corso A; Cilloni D; Cardinali V; Turrini M; Trentin L; Cuneo A; Della Porta M; Massaia M; Fracchiolla N; et alii...

2022
AOU Novara

Chiattone C; Civallero M; Fischer T; Miranda E; Manni M; Zing NPC; Pileri SA; Montoto S; Horwitz SM; Cabrera ME; De Souza CA; Nagler A; Luminari S; Ferreri AJM; Carson KR; Re A; Rigacci L; Nassi L; Stepanishyna Y; Federico M; Inghirami G;

2022
AOU Alessandria
AOU Novara

Inzoli A; Cantore N; Ferreri AJM; Cerqueti M; Santini S; Turrini M; Arcaini L; Caparrotti G; Battistini R; Murineddu M; Camera A; Marino D; Musto P; Stelitano C; Corradini P; Ferrando P; Mannina D; Guarini A; Fraticelli V; Ladetto M; Liberati AM; Santoro A; Consoli U; Mengarelli A; Gaidano G; Petrini M; Cardinale G; Ronci B; La Nasa G; et alii...

2021
AOU Città della Salute di Torino
AOU Novara

Liberati AM; Novak U; Osborne W; Frezzato M; Fox CP; Davies A; Cascavilla N; Bernardi M; Gastaldi E; Cozens K; Bromberg JEC; Singh V; Fanni A; Re F; Patti C; McKay P; Olivieri J; Linton K; Nassi L; Cellini C; Botto B; Cattaneo C; Khwaja J; Luppi M; Calimeri T; Doorduijn JK; Re A; Cabras MG; Smith J; et alii...

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL). in Frontiers in oncology / Front Oncol. 2021 Nov 5;11:730194. doi: 10.3389/fonc.2021.730194. eCollection 2021.
2021
AOU Città della Salute di Torino
AOU Novara

Chiappella A; Rusconi C; Ferreri AJM; Cabras MG; Annibali O; Gentile M; Olivieri A; Loseto G; Arcari A; Tisi MC; Nassi L; Di Rocco A; Gini G; Balzarotti M;

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Mar;23(3):729-735. doi: 10.1093/annonc/mdr289. Epub 2011 Jun 21.
2012
AOU Novara

Mian M; Scandurra M; Chigrinova E; Shen Y; Inghirami G; Greiner TC; Chan WC; Vose JM; Testoni M; Chiappella A; Baldini L; Ponzoni M; Ferreri AJM; Franceschetti S; Gaidano G; Montes-Moreno S; Piris MA; Facchetti F; Tucci A; Nomdedeu JF; Lazure T; Uccella S; Tibiletti MG; Zucca E; Kwee I; Bertoni F;

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Mar;22(3):689-695. doi: 10.1093/annonc/mdq416. Epub 2010 Sep 1.
2011
AOU Novara

Conconi A; Martinelli G; Lopez-Guillermo A; Zinzani PL; Ferreri AJM; Rigacci L; Devizzi L; Vitolo U; Luminari S; Cavalli F; Zucca E;